Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’?
A significant number of SARS-CoV-2 (COVID-19) pandemic patients have developed chronic symptoms lasting weeks or months which are very similar to those described for myalgic encephalomyelitis/chronic fatigue syndrome. This study reviews the current literature and understanding of the role that mitoc...
Guardado en:
Autores principales: | Emily Wood, Katherine H. Hall, Warren Tate |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a8c1d4d6bfb4492997ea025186013f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Kavya Srinivasan, et al.
Publicado: (2021) -
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Klaus J. Wirth, et al.
Publicado: (2021) -
Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Helen Brownlie, et al.
Publicado: (2021) -
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
por: Manuel Ruiz-Pablos, et al.
Publicado: (2021) -
The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
por: Iñigo Murga, et al.
Publicado: (2021)